According to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...

The epigenetic technologies market is witnessing remarkable growth as researchers and healthcare organizations increasingly focus on understanding gene regulation mechanisms and their impact on disease development. Epigenetics has emerged as a critical area of life science research, offering insights into how environmental factors and cellular processes influence gene expression without...

The global gene editing market is experiencing substantial growth driven by continuous advancements in genomic technologies, increasing demand for precision medicine, and rising investments in biotechnology research. Gene editing technologies are transforming modern healthcare by enabling precise modifications in DNA sequences to treat genetic disorders, cancer, and chronic diseases. The...

The global genetic testing services market is experiencing remarkable growth due to the increasing adoption of precision medicine, rising awareness regarding hereditary diseases, and rapid advancements in genomic technologies. Genetic testing services are becoming essential across healthcare systems for disease diagnosis, risk assessment, treatment planning, and preventive healthcare...

The global mRNA sequencing market is witnessing remarkable expansion as healthcare systems, pharmaceutical companies, and research institutions increasingly adopt advanced sequencing technologies for disease diagnosis, precision medicine, and therapeutic development. mRNA sequencing has become an essential tool for transcriptome analysis, enabling researchers to study gene expression patterns,...

The growing focus on preventive healthcare and early detection of inherited genetic disorders is significantly driving the demand for carrier testing services across North America. Advances in molecular diagnostics, increasing awareness regarding reproductive health, and the rapid adoption of precision medicine are transforming the genetic testing landscape. Healthcare providers and diagnostic...

North America holds a significant share of the DNA microarray chips market, driven by increasing research and development activities, widespread adoption of molecular diagnostics, and growing demand for genomic testing. The region benefits from well-established healthcare infrastructure, favorable funding for biotechnology research, and continuous technological advancements in genomic analysis...

The pharmaceutical and biotechnology industries across North America are rapidly adopting advanced informatics solutions to accelerate drug discovery and improve research efficiency. The increasing need to reduce drug development timelines, manage large biological datasets, and enhance precision in clinical research is driving the demand for innovative informatics platforms. The market is...

The pharmaceutical and biotechnology industries across North America are rapidly adopting advanced informatics solutions to accelerate drug discovery and improve research efficiency. The increasing need to reduce drug development timelines, manage large biological datasets, and enhance precision in clinical research is driving the demand for innovative informatics platforms. The market is...

The global Sanger sequencing service market is experiencing robust growth due to the increasing demand for accurate DNA sequencing technologies in clinical diagnostics, pharmaceutical research, biotechnology, and academic studies. Sanger sequencing remains one of the most reliable methods for validating genetic variations, mutation detection, and targeted sequencing applications. The Sanger...